Thanks for visiting Research Information.

You're trying to access an editorial feature that is only available to logged in, registered users of Research Information. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Proteomics - Clinical Applications (PCS)

Share this on social media:

Wiley-VCH will launch Proteomics – Clinical Applications (PCA), a new journal intended to cover information in the field of applying proteomics to the study of human disease and translation to the clinic.

According to Wiley, the parent journal, Proteomics, has achieved an impact factor of 6.088 (ISI 2005) after six years of publication. As a result, Proteomics – Clinical Applications is to be published as a standalone journal from 2007. With 12 issues a year, PCA will focus on clinical research, including dysfunction in human disease, validation of diagnostic and prognostic disease biomarkers, novel drug targets and clinical trials.

Company: